Arimoto M, Yokohama S, Sudou M, Ichikawa Y, Hayano T, Tagawa H, Furukawa M
Research Institute, Daiichi Seiyaku Co., Ltd., Tokyo, Japan.
J Antibiot (Tokyo). 1988 Dec;41(12):1795-811. doi: 10.7164/antibiotics.41.1795.
A series of 7 beta-[2-(hetero aromatic methoxyimino)-2-(2-aminothiazol-4-yl)acetamido]- cephalosporins have been synthesized and bacteriologically evaluated. Several substances in this series showed exceptional in vitro activity, especially those with a five-membered hetero aromatic substituent moiety at the 7-position and a quaternary ammonium group as the 3-function of the cephem nucleus. The most active derivative, 7 beta-[2-(imidazol-4-ylmethoxyimino)-2-(2-aminothiazol-4-yl)a cetamido]-3-(pyridiniomethyl)ceph-3-em-4-carboxylate (13a) was the most evenly balanced with respect to activity against Gram-positive and Gram-negative bacteria. Furthermore, 13 was stable to various types of beta-lactamases and had high affinities for penicillin binding protein-3 and -1Bs of both Escherichia coli and Pseudomonas aeruginosa.
合成了一系列7-β-[2-(杂芳基甲氧基亚氨基)-2-(2-氨基噻唑-4-基)乙酰胺基]头孢菌素,并进行了细菌学评估。该系列中的几种物质表现出优异的体外活性,特别是那些在7位具有五元杂芳基取代部分且作为头孢烯核3-位功能基团的季铵基团的物质。活性最高的衍生物,7-β-[2-(咪唑-4-基甲氧基亚氨基)-2-(2-氨基噻唑-4-基)乙酰胺基]-3-(吡啶甲基)头孢-3-烯-4-羧酸酯(13a)在抗革兰氏阳性菌和革兰氏阴性菌的活性方面最为平衡。此外,13对各种类型的β-内酰胺酶稳定,并且对大肠杆菌和铜绿假单胞菌的青霉素结合蛋白-3和-1Bs具有高亲和力。